Transthyretin Amyloidosis Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Transthyretin Amyloidosis Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy
A completed real-world study assessing high-dose tafamidis for its effect on neurologic disease progression in patients with mixed-phenotype…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
AstraZeneca-sponsored clinical trial evaluating transthyretin amyloidosis cardiomyopathy in patients with heart failure with preserved eject…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology
Completed clinical trial assessing the prevalence and characteristics of transthyretin amyloidosis in patients with left ventricular hypertr…